Sort
39,280 grants matching “leukemia”
Investigating hematopoietic stem cell dysfunction during sickle cell disease
$708,579Shannon L McKinney-Freeman · St. Jude Children'S Research Hospital · R01 · FY2025 · HL
Conformal Total Body and Marrow Irradiation for Leukemia
$708,512Susanta K Hui · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Tissue Core
$708,359Laura Z Rassenti · University Of California, San Diego · P01 · FY2008 · CA
Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia
$708,057Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
GENETIC RISK FACTORS FOR CLONAL HEMATOPOIESIS AND LEUKEMIA DEVELOPMENT FOLLOWING IONIZING RADIATION AND CHEMICAL EXPOSURE
$708,000Children'S Hospital Corporation, The · · FY2016 · Department of the Army
Pediatric Clinical Oncology Research Training Program
$707,872David G. Poplack · Baylor College Of Medicine · K12 · FY2008 · CA
The role of inflammation in driving leukemogenesis in germline predisposition syndromes
$707,850Lucy Ann Godley · University Of Chicago · U01 · FY2022 · CA
Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7
$707,740Guohua Yi · University Of Texas Hlth Ctr At Tyler · UG3 · FY2019 · AI
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$707,707William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2017 · GM
Referral Center-Animal models of human genetic disease
$707,612Mark E Haskins · University Of Pennsylvania · P40 · FY2014 · OD
Glia maturation factor-gamma modulation of signaling pathways in macrophages
$707,429Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Transplant Models
$707,370Ronald Gress · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$707,291Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Low-Cost User-Friendly Otoacoustic Emissions Probe
$707,124Odile H Clavier · Creare, Llc · R44 · FY2017 · DC
Novel Cellular Therapies for Ph+ leukemia
$707,089Richard A. Van Etten · Tufts Medical Center · R01 · FY2009 · HL
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
$706,749Steven M Larson · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Cincinnati Neuro-Oncology Research Core
$706,666Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · P30 · FY2009 · CA
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals
$706,519Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2025 · MH
Understanding the mechanisms of chromosomal aberrations in cancer
$706,409Thomas Ried · Basic Sciences · Z01 · FY2007 · CA
Balanced signaling cues to guide cell transitions in the blood lineage continuum
$706,126Jeroen Roose · University Of California, San Francisco · R01 · FY2019 · HL
Mechanosensitive determinants of podocyte physiology
$706,019Evren U. Azeloglu · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
HDAC Inhibition to prevent GVHD
$705,818Pavan Reddy · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · CA
Outcomes for CLL patients treated with novel therapy
$705,542Neil E Kay · Mayo Clinic Rochester · R01 · FY2021 · CA
CORE C Technology Implementation/Development and Correlative Sciences
$705,526Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2025 · CA
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$705,167Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA